WHAT MECHANISMS ENABLE context-dependent cell signaling? That is, how can molecular interactions in the cell's microenvironment combine with those within the cell to modulate response to a particular stimulus? In part, the specificity of a cell's response is built into the molecular makeup of signal transduction networks (37) . Receptor binding by soluble ligands, such as growth factors, is translated into cellular responses by signaling pathways, which rely for their activation on a number of adaptors and enzymes. In this way, activation of identical receptors in two cells with different sets of adaptors and enzymes stimulates different signaling pathways, resulting in two different responses. The induced responses may differ in the nature of the stimulated signaling pathways and/or in the dynamic properties of their activation (48) . The extracellular context, e.g., composition of the extracellular matrix (ECM), can affect the signaling response by creating the intracellular background that dynamically interacts with signaling induced by exogenous signals, such as soluble growth factors (31, 56) . Previously proposed mechanisms of context-dependent "processing" of external stimuli focus on this kind of intracellular synergy of multiple inputs (63, 66) . We suggest the existence of a complementary mechanism that enables cells to process external stimuli both intra-and extracellularly. This mechanism may be operative in autocrine loops formed by growth factors and their receptors.
Autocrine loops are established when soluble factors secreted by cells bind to and stimulate receptors on their own surfaces (64) . Commonly, secretion of autocrine ligands is tightly regulated. In the epidermal growth factor (EGF) receptor (EGFR) system, ligands such as transforming growth factor-␣ (TGF-␣) are synthesized in the form of membrane-bound precursors (49) . Thereafter, ligand-releasing proteases, also known as "sheddases" [e.g., tumor necrosis factor-␣ (TNF-␣)-converting enzyme (TACE)], process the membraneassociated precursors into their active soluble forms (49, 54, 70) . The characteristically high levels of cognate receptors expressed by autocrine cells make them very efficient in recapturing endogenous ligands (15, 19, 44, 53, 62, 72) . Along with the mechanisms for ligand release and capture, autocrine systems are equipped with numerous mechanisms for cross activation (10, 50, 55, 75) . Response to a primary stimulus, such as an exogenous growth factor, a component of the ECM, or ionizing radiation, can lead to ligand release and recapture and stimulation of intracellular signaling (16, 30, 58) . In nonautocrine cells, soluble growth factors were shown to activate sheddases through the Ras-mitogen-activated protein kinase (MAPK) pathway (23, 26) , one of the central pathways activated by receptor tyrosine kinases such as EGFR. This suggests that, in an autocrine EGFR system, a ligand, the receptor, the sheddase, and the intracellular signaling network can form a positive-feedback loop (52) .
The spatially restricted and recurrent nature of autocrine loops makes their experimental analysis very challenging. As an aid to the experimental studies of autocrine loops in the EGFR system, we integrate the biochemical and biophysical knowledge about EGFR signaling into a mechanistic mathematical model. The model accounts for the dynamic interaction between ligand release, diffusion in the extracellular medium, receptor binding, and Ras-MAPK pathway activation. We find that the positive feedback endows autocrine cells with nontrivial signal-processing capabilities. We propose a mechanism for modulating the amplitude and duration of Ras-MAPK activation induced by external stimuli; these characteristics of MAPK signaling are critical for a number of cellular responses (48, 56) . Using our model, we demonstrate that this mechanism provides a substrate for context-dependent cell signaling. Furthermore, our analysis enables the direct interpretation of the context-dependent radiation responses of autocrine cells. In human carcinoma cells, the EGFR-TGF-␣ autocrine loop defines cellular response to radiation (survival or death) by regulating the duration and amplitude of the Ras-MAPK activation (16) .
This report is organized as follows. In COMPUTATIONAL MODEL FOR AUTOCRINE CELL-SIGNALING LOOP, we describe the modules for ligand release, binding and transport, and intracellular signaling. Then we describe how these individual modules are integrated in a model of an autocrine loop. In RESULTS, we focus exclusively on the processes defining the operation of autocrine systems. Equations and details of their analysis can be found in APPENDIX A. After identifying the key parameters governing the operation of individual modules, we proceed to analysis of the integrated system; we focus on the effects of the feedback loop formed by the receptor, the signaling cascade, and the system for ligand release. This sets up the framework for the analysis of the experiments reporting context-dependent radiation responses of autocrine cells in the DISCUSSION. These experiments support our modeling predictions, demonstrating that the composition of the extracellular medium, in this particular case the presence or absence of ligand-binding antibodies, can critically influence the cell response.
COMPUTATIONAL MODEL FOR AUTOCRINE CELL-SIGNALING LOOP
The biochemical events that we aim to model are summarized in Fig. 1A . Initial activation of a growth factor receptor stimulates downstream signaling pathways (e.g., the Ras-MAPK pathway) that, by unknown mechanisms (23, 26) , increase the activity of sheddases and lead to release of soluble growth factor(s). Localized capture of endogenous ligands increases the number of occupied receptors and initiates a secondary stimulation of the receptor and downstream signaling pathways. The positive-feedback loop-receptor/ signaling/sheddase/ligand/receptor-governs the duration and amplitude of the signaling transient in response to external perturbation.
Model of Ligand Binding and Transport
Equilibrium and kinetic parameters for binding and trafficking in growth factor receptor systems, including the ErbB1-4 system, have been well documented (18, 43, 60) ; furthermore, experiments reporting diffusivities of growth factors in tissues have recently started to appear (21) . Our model of binding and transport ( Fig.  2A ) accounts for the concentration of endogenous ligand (L) and the surface densities of free and occupied surface receptors (R s and C s , respectively). We consider a single autocrine cell; the cell is modeled as a hemisphere with radius r cell , placed on an infinite plane (this mimics an autocrine cell attached to a substrate). Ligand secretion, at rate Q, is uniformly distributed over the cell surface area (A). Ligand released in the extracellular medium diffuses with constant diffusivity (D) and reversibly binds to cell surface receptors with binding constant K d . Newly synthesized receptors arrive at the cell surface with rate S; they are constitu- Fig. 1 . Schematic illustration of ligand-induced autocrine growth factor release mediated by receptor-activated intracellular signaling. In the epidermal growth factor (EGF) receptor (EGFR) system, ligands of the EGFR are shed from the cell surface by surface metalloproteases activated (among other things) via the extracellular signal-regulated kinase (ERK)-mitogen-activated protein kinase (MAPK) cascade; the same cascade is activated when autocrine ligands bind to receptors on the surface of the releasing cell. TGF-␣, transforming growth factor-␣; TACE, tumor necrosis factor-␣-converting enzyme.
tively internalized with rate constant k c and are converted to surface complexes with rate constant k on . Surface complexes dissociate with rate constant k off ϭ k on K d and are removed from the cell surface by endocytosis with rate constant k e . Endogenous ligand can reversibly bind to the extracellular "decoys" (molecules that mimic soluble antiligand antibodies) (12, 25, 44 
Model of Protease Activation
Ligand-releasing proteases have only recently been added to the "parts list" of the autocrine loops (7, 19, 54, 70) ; so far, mathematical modeling of protease activity has not been attempted. The main facts in the rapidly accumulating information on the molecular nature, mechanism of action, and dynamics of sheddases can be summarized as follows. Ligand-releasing proteases are not specific and are capable of processing a wide range of surface molecules (7); members of the EGFR ligand family are just one example (70) . The rate of ectodomain cleavage depends on the juxtamembrane domain of the precursor molecule (20, 51) . Sheddases are under the control of multiple intracellular signaling pathways; secretion is composed of a slow process mediating the constitutive release and faster inducible process (23, 26) . The inducible activation can occur as fast as 10-15 min after application of the stimulus (26) . The activation of protease is followed by its removal from the surface, most likely via the endocytic pathway (17) . In our model (Fig. 3A) , we assume that newly synthesized protease is inserted in the membrane with the rate S P and constitutively internalized with the rate constant k c P . The protease is converted to the "active" form with the rate constant k a P ; the active form is internalized via endocytosis with the rate constant k e P . The model is formulated in terms of variables P and P a , denoting the amount of protease in the inactive and active states (see APPENDIX A).
Model of Signaling Cascade
Previously introduced dynamic models of the MAPK cascade account for the dynamic changes of enzymes at the three levels of the cascade and the negative feedback exerted by the active form of the last enzyme on the input to the network (34, 39, 47) . For our purposes, we need the simplest possible model that would be consistent with the previous descriptions and evolve on the time scales observed in time-resolved assays of MAPK activity (2) . Our model of the MAPK cascade (Fig. 3A) consists of three enzymes, E 1 , E 2 , and E 3 (Fig.  4A) . The three stages in the cascade model the sequen- serving to provide the network with transient inputs (36, 50, 57) .
Coupled System
The integrated model is assembled from the individual blocks on the basis of the information available about their coupling (Fig. 5 ). Ligand-mediated receptor phosphorylation and signaling complex assembly, linking the act of ligand receptor binding to the MAPK cascade, were recently modeled by a sequence of reversible reactions (6, 8, 41) for receptor phosphorylation and signaling complex assembly; detailed kinetic modeling of these events is beyond the scope of this work. Activation of ligand-releasing proteases mediated by the MAPK has been conclusively demonstrated (23, 26, 29) . The first kinetic analysis of the proteolytic release of the EGF-family ligands has been recently reported; it has been shown that the rate of ligand release obeys pseudo-first-order kinetics with respect to the amount of surface protease (20) . In the absence of more detailed information, linear gains (in other words, linear proportionality of cause and effect) provide the simplest possible descriptions of the (nonlinear) interconnections between the modules comprising the autocrine loop. First, the endogenous input to the signaling cascade is proportional to the number of surface complexes. Second, the rate constant of protease activation is proportional to the amount of the active form of the last enzyme in the signaling cascade. Finally, the rate of ligand secretion is proportional to the fraction of the protease in the active form. The system of equations describing the integrated model is presented in APPENDIX A.
RESULTS

Analysis of the Model
Transport and binding. The rate of diffusion of endogenous ligand away from the cell surface is defined as the number of molecules released per unit area in unit of time; it is termed the "flux" (F). F depends on the amount of secreted ligand and the ability of the autocrine cell to remove the endogenous ligand from the extracellular medium by binding and receptormediated endocytosis. The ratio of F to the rate of ligand secretion quantifies the fraction of autocrine ligands escaping from the releasing cell. The remaining fraction of secreted ligand defines the (steady) probability of ligand capture: P cap ϵ 1 Ϫ F/Q. Within our model, P cap is related to the binding/transport parameters by the following expression
where
The first of these dimensionless groups (Au) is the autocrine number, equal to the ratio of the ligand concentration at the cell surface in the absence of surface receptors to the dissociation constant of a ligand-receptor pair. The second, Da, is the Damköhler number, which quantifies the relative importance of ligand binding and transport (14) . The third group, ␥, compares the rate at which free receptors are removed by constitutive internalization with the rate at which they are freed by dissociating complexes. Finally, for a bound ligand, ␦ is the probability of being internalized. Detailed analysis of Eq. 1 is reported elsewhere (62) . Note that when calculating the recaptured fraction of autocrine ligands using Eq. 1, we discount those that were bound by the cell, dissociated, and then "lost" to the extracellular medium. However, even those ligands that had been on the surface only transiently may contribute to receptor activation. By setting the rate of ligand dissociation to zero (Eq. 1), we consider only the processes that occur before the first binding event. In this way, we obtain a fraction of endogenous ligands that were bound by the cell at least once receptors), which may utilize endocrine mechanisms for their growth and survival. Furthermore, interaction of secreted growth factors with the components of the ECM has the potential to make their effective diffusivity after cleavage and release relatively low (21) . We conclude that, at least in the EGFR system, autocrine cells have the potential to recover a significant fraction of endogenous ligand. Figure 2B presents the recaptured fraction of autocrine ligands computed as a function of the total number of surface receptors (in the model, R T ϭ S/Ak c , where R T is the total number of surface receptors) and the magnitude of extracellular ligand diffusivity. The extent to which autocrine cells interact with their environment may be estimated by analyzing the statistical properties of the random trajectories followed by autocrine ligands. Let d max be the maximal distance to which a particle released on the surface of a hemisphere had diffused before being bound by one of the receptors that are uniformly distributed over the surface. Then, d max defines a random variable with the distribution function dependent on the density of surface receptors (R T ), the extracellular ligand diffusivity, and the forward binding constant. By characterizing the statistical properties of the maximal distances traveled by recaptured autocrine ligands, the distribution function for r max characterizes the spatial range of autocrine signals. Using the tools for analyzing the extreme properties of Brownian paths (68), we arrive at the following expression for the cumulative distribution function of d max [we consider only those ligands that have been recaptured by the releasing cell; hence, the distribution function (Eq. 4) asymptotes to 1]
where P{d max d} denotes the probability that the random variable d max is less than d.
In Fig. 2C , this distribution function is plotted for the binding parameters characteristic of the EGFR ligand-receptor interaction, 10 5 cell surface receptors (within the range reported for autocrine EGFR systems, i.e., 10 4 -10 6 ), and several values of extracellular ligand diffusivity. Computations based on Eq. 4 indicate that, before their recapture, autocrine ligands sample a very small volume; a significant fraction of autocrine ligands is recaptured after traveling only a few micrometers from the cell surface. This spatially restricted character of autocrine loops may account for the initial difficulties in the experimental detection of autocrine ligands in the extracellular medium [13; see also discussion of other experiments in a recent review of EGFR transactivation (28)]. Because the main parameter defining the range of autocrine loops is a Damköhler number (Eq. 2) that depends on the combination of ligand diffusivity, receptor density, and the forward binding constant, all these factors may contribute to tuning the range of autocrine signals.
The results of simulations presented in Fig. 2D show that steady levels of receptor occupancy may be attained within 20 min after the steplike increase in the rate of ligand release. The maximal steady number of surface ligand-receptor complexes predicted by our model is k c R T /k e . However, this number can be exceeded in the transient operation of autocrine loops; as illustrated by one of the transients in Fig. 2D , the time course of the number of surface complexes need not be monotonic. Indeed, it has been observed that the high levels of receptor activation, inferred from the levels of receptor tyrosine phosphorylation, can be attained very quickly after activation of the ligand release system (28) .
Protease dynamics. The amount of surface protease in the active form is determined by the balance between the processes for its synthesis, activation, and degradation. Within our model, the total amount of activated protease under steady-state conditions is given by the following expression
where and depend on the rate constants for the processes of protease constitutive degradation, activation, and degradation of the active form: ϭ k c P /k e P and ϭ k a P /k e P . In the absence of activation ( ϭ 0), the total amount of surface protease is S P /k c P . As the rate of protease activation increases, the amount of the active form grows and approaches the asymptote defined by the balance of its synthesis and the endocytosis of the active form: S P /k e P (Fig. 3B ). One can show that whenever the rate constant of constitutive degradation is smaller than the rate constant for degradation of the active form ( Ͻ 1), the total amount of the protease will be a decreasing function of the activation rate constant. Hence, activation of the ligand-releasing protease will be accompanied by its downregulation from the cell surface. Doedens and Black (17) recently demonstrated such stimulationinduced downregulation of the surface metalloprotease for TACE. Because TACE has been implicated in releasing the EGFR ligands (19, 54) , this observation is directly related to the operation of the EGFR autocrine loops. In these experiments, it was found that the active form is removed from the surface via an endocytic pathway (36) . As the first approach to modeling this problem, we take the rate constant of active protease degradation equal to the endocytic rate constant for the surface ligand-receptor complexes.
The dynamic evolution of the active and inactive forms of the surface protease after a steplike increase in the activation rate constant is presented in Fig. 3 , B and D. Although the dynamics of the inactive fraction of the enzyme are always monotonic, the evolution of the active form of the enzyme can exhibit a strong overshoot (i.e., exceed the value to which it eventually settles) before settling to the steady value predicted by Eq. 5. This effect may be important for the operation of autocrine loops: under the conditions of the efficient ligand recapture (see Transport and Binding), largeamplitude overshoot in the activity of ligand-releasing enzyme will be registered by the cell surface receptors and relayed to the downstream signaling pathways.
Signaling. Because our model for signaling through the MAPK cascade is closely related to the previously reported models (6, 34, 39) , we provide only a brief summary of the intracellular signaling module of the autocrine loop. The input-output behavior of a single stage is critically dependent on the degree of saturation of the enzymes catalyzing the forward and reverse phosphorylation-dephosphorylation reactions (27) . When these enzymes operate close to saturation with respect to their substrates, even a single stage can exhibit sigmoidal input-output dependence. Several stages characterized by the relatively graded input-output behaviors can form a cascade with a very steep inputoutput response (34, 40) . The steady input-output behavior of our modeling cascade is shown in Fig. 4B . The output is negligible below a certain threshold value; past that value, the output increases to its maximal value within a very narrow range of inputs (27, 34) . In the cell, this network is under the control of multiple loops that can attenuate or desensitize signaling pathway activity (47) . Incorporating the presence of negative feedback in the model affects the input-output behavior: transformation from essentially null to full activation of the last element occurs, now, over a wider range of inputs (Fig. 4B) . Multiple stages of the signaling cascade separating its input and output lead to an effective time delay in the dynamic input-output response (not shown). Negative feedback coupled with kinetic time lags can give rise to oscillatory behavior, i.e., periodic oscillations, even for fixed values of external conditions. To distill the dynamic effects mediated by positive-feedback loops (from ligand binding to ligand secretion), we have chosen to work in the region of parameters that does not support oscillatory behavior. Thus, for all the simulations reported below, the input-output behavior of the signaling module is stable.
Computational analysis of the integrated model. We have analyzed the response of our model autocrine loop to pulselike excitations of the signaling cascade (Fig.  6A) . Inputs of short duration can be delivered to the MAPK cascade by different means, e.g., by integrins, one of the numerous growth factor receptor systems, or ionizing radiation (10, 30, 47, 50, 75 ). In our model, activation of the signaling cascade stimulates ligand release and increases receptor occupancy. We have explored the conditions under which this effect leads to a noticeable modulation of the primary excitation. Under the "open-loop" conditions (low number of surface receptors, inhibited receptor or signaling pathway activity), the primary excitations lead to transient, lowamplitude elevation of the activity of the last element of the signaling cascade (lower curves in the transients in Fig. 6, B-D) . This primary excitation of the output simply reflects the pulse response of the intracellular signaling cascade. As the number of cell surface receptors is increased, this dynamic response is strongly modulated. Specifically, a secondary excitation of large amplitude and duration appears in the response (Fig.  6B) . Simultaneously, the time scale of the dynamic response is dramatically increased from 40 min to several hours. The emergence of long-lasting secondary excitations is critically dependent on the ability of an exogenous signal to cross activate the ligand-releasing protease. See the change in the response shape as a function of the coupling strength between the output of , kon ϭ 10
, k a,0 P ϭ 0.001 min Ϫ1 , k e P ϭ 0.1 min Ϫ1 , G2 ϭ 5 ϫ 10 Ϫ4 , G3 ϭ 1, and G4 ϭ 1. Michaelis constants of reactions at the 3 stages of the signaling cascade are the same as in the signaling cascade and the rate constant of protease activation (Fig. 6C) . Hence, the ability of an autocrine cell to recapture endogenous ligands released in response to exogenous stimuli provides a flexible mechanism for tuning the duration of the intracellular signaling response. Our computational analysis shows that, depending on parameters of the integrated network, the amplitude of secondary excitation can be lower and higher than that of the primary excitation (Fig. 7B) . The amplitude of the external perturbation has to be sufficiently large to induce the long-lasting response with secondary excitations (Fig. 6D) . In this way, the quantitative difference of the transient input, e.g., its input, may be translated into the qualitative differences of the output, such as the number of maxima in the induced response.
A combination of the strong nonlinearity of the intracellular signaling cascade (Fig. 4B) with the positive feedback can result in a phenomenon known as "bistability" (24) . Bistability is defined as the ability of the system to exist in two stable configurations at fixed external conditions; selection of a particular stable configuration depends on the history of the system. Indeed, in regimens characterized by stronger coupling between the ligand-releasing protease and ligand secretion rate, larger number of receptors, or weaker gain of the negative feedback in the signaling cascade, the system can exist in one of the two stable ("on" and "off") configurations (Fig. 7A) . The off state is characterized by a low level of signaling, low levels of endogenous ligand production, and a low number of occupied surface receptors. In the on state, large quantities of signal circulate through the autocrine loop: the cell secretes high levels of ligand and captures a significant fraction of it. The captured ligand further increases the level of intracellular signaling and, as a result, a high secretion rate. In Fig. 7A , the steady input-output behavior of the autocrine loop is shown as a function of the strength of the exogenous input. Below a critical input magnitude the on and off states coexist; above this threshold, the off state can no longer be maintained, and the system switches to the state characterized by the high levels of signaling, receptor occupancy, and ligand release. The autocrine system in a bistable regimen can be flipped between the two steady states by transient inputs. Figure 7B demonstrates that, after a primary excitation, the system can become permanently locked in the on state. Hence, a transient input can induce a permanent transformation of the signaling state of the cell. The switching ability of the transient input is conditional on the autocrine cell's ability to release endogenous ligand (Fig. 7B ) and to recapture endogenous ligand (not shown).
To be recaptured by the releasing cell, the secreted ligand clearly must return to the cell surface. Return of autocrine ligands can be prevented by a component of the extracellular medium capable of binding the secreted ligand and removing it from the autocrine loop. The components of the extracellular medium, such as exogenously added antiligand antibodies, may serve as such decoys for autocrine ligands (25) ; notice that the components of the ECM, such as heparin, may also act as extracellular "sinks" for autocrine ligands (38) . We illustrate this by computing the signaling patterns induced in our model autocrine cell when it is placed in the medium with the various concentrations of extracellular decoys. Figure 7C illustrates that the on state of an autocrine loop exists only below a certain threshold concentration of the extracellular decoys that sequester the endogenous ligand. This qualitative change in the steady behavior is mirrored by changes in the dynamic response to a pulselike exogenous stimulus (Fig. 7D) . The persistent response is converted to a prolonged transient that is eventually abolished by increasing the concentration of extracellular decoys. This demonstrates the context-dependent signaling capability of autocrine loops: the dynamics of intracellular signaling may be regulated by the composition of the extracellular medium. In contrast to the previously proposed modes of cell signaling, this mode is bidirectional: signals flow into and out of the cell.
Comparison With Experiment
Context-dependent radiation responses of human carcinoma cells. Pulse responses with large-and intermediate-amplitude secondary excitations for EGFR and MAPK signaling were recently reported in studies examining DU145 prostate and A431 squamous carcinoma cells. Similar to the modeling predictions, a pulselike input to the system (a pulse of ionizing radiation) was modulated by the autocrine loop, resulting in complex output (MAPK activity) dynamics. The signaling dynamics are strongly dependent on the actions of the autocrine ligand TGF-␣. A description of the experimental protocols is given in APPENDIX B and in Refs. 16, 30, and 58. In the experiments, EGFR-expressing carcinoma cells were exposed to a clinically relevant low dose of ionizing radiation (2 Gy) and assayed for EGFR tyrosine phosphorylation and MAPK activity (16, 30, 58) . The response of EGFR tyrosine phosphorylation and MAPK activity consisted of an initial short (0-30 min) primary activation followed by secondary activations of 120-240 min in A431 squamous carcinoma cells (Fig. 8A) and 120-1,440 min in DU145 prostate carcinoma cells (not shown). In both cell types, the secondary excitation of MAPK could be completely abolished by interrupting the TGF-␣-EGFR autocrine loop. This was demonstrated experimentally by inhibiting EGFR tyrosine kinase activity (not shown) and by adding antibodies absorbing the se- Fig. 8 . Radiation causes a biphasic activation of the MAPK pathway in autocrine carcinoma cells; secondary activation of the MAPK pathway is dependent on cleavage and release of TGF-␣. A: cells were irradiated, and MAPK activity was determined as described previously (16, 30) . In the indicated experiments, anti-TGF-␣ antibody (1 g/ml media) was added before irradiation. Cells were lysed, portions (ϳ100 g) from each plate were used to immunoprecipitate MAPK, and immune-complex kinase assays were performed (16, 30) . Data are from a representative experiment (n ϭ 5). B: A431 cells were irradiated, medium was removed from irradiated cells 120 min after exposure, and anti-TGF-␣ antibody or control antibody was added to the recovered medium. Isolated medium was incubated with antibody for 60 min, and then nonirradiated cells were added. After 5 min, the plates were aspirated and snap frozen, and MAPK activity was determined after immunoprecipitation (16, 30) . MAPK activity data are shown as fold increases in 32 P incorporation into myelin basic protein substrate and are normalized to activity at time 0. Values are means Ϯ SE of 3 independent experiments. creted TGF-␣ (Fig. 8A) . When the medium from the irradiated cells was transferred to nonirradiated cells, 2 h after exposure, a comparable MAPK activation was induced in the nonirradiated cells that was dependent on soluble TGF-␣ in the transferred medium (Fig. 8B) . To summarize, experiments in Fig. 8 demonstrate that the primary exogenous stimulus (radiation, in this particular case) activates autocrine loops and that this activation depends on the composition of the extracellular medium. Figure 8A shows that secondary excitation in MAPK activity disappears when radiation stimulates the cells placed in the medium containing antiligand antibodies. A complementary experiment in Fig. 8B shows that medium from the irradiated cells can stimulate MAPK in the nonirradiated cells; this effect is abolished when antiligand antibodies are added to the conditioned medium.
Enhanced ligand secretion and prolonged MAPK activity in the irradiated cells could be abolished when the A431 squamous carcinoma cells were treated with PD-98059, an inhibitor of the enzyme MEK1/2, acting upstream of MAPK in the kinase cascade. In these cells, the basal release of TGF-␣ over a 3-h period was ϳ60 pg/mg total cell protein. Irradiation (2 Gy) increased TGF-␣ release by ϳ80%; this release was blocked when irradiated cells were incubated with the MEK1/2 inhibitor PD-98059 (data not shown). Similar data for regulation of TGF-␣ release, using ligand stimulation of the EGFR-MAPK system, have been reported in other cell types (16, 30, 58) . Collectively, these experiments support an MAPK-mediated positive-feedback loop between ligand binding and ligand release.
Interestingly, the dynamics of MAPK signaling observed in these irradiated autocrine cells indicate the presence of the multiple steady states (16, 30, 58) . As in our computational study, transient input seems to permanently lock MAPK in the active on state in DU145 cells, whereas in A431 cells the duration of secondary MAPK activation was only 2-3 h (16, 30, 45) . The greater secondary activation of MAPK in DU145 cells may be explained because these cells have a genetic rearrangement of the TGF-␣ gene, resulting in its triplication (11) , and thus express more autocrine ligand than A431 cells.
DISCUSSION
We have developed a mechanistic model of autocrine loops in the EGFR system (Fig. 9) . The model accounts for the dynamic interaction of ligand release, extracellular transport, receptor binding, and signaling through the Ras-MAPK pathway. Our computational analysis demonstrates that autocrine loops with positive feedback allow cells to modulate the amplitude and the duration of the signaling response to external stimuli. Fig. 9 . Concept of context-dependent cell signaling mediated by positive feedback in autocrine loops. Amplitude and duration of activation of an intracellular signaling cascade by exogenous stimulus depend on the primary stimulus, its ability to activate the ligand-release system, and the ability of the cell to recapture endogenous ligands. Autocrine loop in the "on" state (A) converts transient external perturbation (B) to a long-lasting and dynamic transient of the intracellular signaling (C). Autocrine loop is interrupted when the cell has a low number of surface receptors (D) or when the endogenous ligands are captured by components of the cellular microenvironment (E). In this case, the exogenous stimulus is incapable of inducing long-lasting or sustained activation of the intracellular signaling circuitry (F).
Specifically, a pulselike input lasting only several minutes induces a signaling transient that lasts for several hours. Furthermore, transient inputs can permanently leave the autocrine loop in the on state, characterized by the high signaling level. Both of these features are demonstrated in the study of the EGFR autocrine loops in human carcinoma cells (see also Refs. 16, 30, and 58) . In these cells, a 1-min pulse of ␥-radiation results in TGF-␣ release and leads to complex MAPK dynamics on the time scale of hours. Sustained activation of the ERK1/2 MAPK in the EGFR-TGF-␣ autocrine loop has also been detected in cancerous pancreatic cells and suggested to be a cause of their serum-free growth (52) . We have focused on the positive feedback that operates exclusively at the level of signaling. Under the additional control of feedbacks acting at the level of gene expression, the nonlinear effects reported here are likely to become even more pronounced.
We have demonstrated that dynamics of autocrine loops with positive feedback are governed jointly by the intracellular and extracellular processes. In particular, interactions of secreted ligands with components of the extracellular environment are translated into the dynamics of the intracellular signaling. On the basis of our computational and experimental studies, we propose that the EGFR autocrine loop with positive feedback is a module for context-dependent signal processing. Two cells equipped with the same intracellular signaling capabilities but different in their ability to release and recapture autocrine ligands may respond differently to the same external input. In this work, the extracellular context, characterized by the presence or absence of antiligand antibodies, is reflected in the MAPK dynamics and defines cell response to radiation: the presence or absence of long-lived MAPK excitations mediated by the EGFR-TGF-␣ autocrine loop defines whether the irradiated cell survives or dies. Further supporting our model of context-dependent signaling is a recent experiment in which the EGFR autocrine loop regulates the ability of a G protein agonist (thrombin) to induce cell migration (38) . There, stimulation of the EGFR by the heparin-binding EGF, released in response to exogenous thrombin, was necessary for thrombin-induced migration of rat and baboon smooth muscle cells; interruption of autocrine signaling by soluble heparin or antiligand antibodies abrogated thrombin-induced cell motility.
On the basis of our computational studies and the experiments reporting the effect of exogenously added soluble antiligand antibodies or other factors interacting with autocrine ligands, we suggest that the composition of the ECM can affect signaling dynamics via a similar bidirectional mechanism. Mathematical analysis of this hypothesis would involve changing the freely diffusing ligand decoys in our model to immobile extracellular components interacting with the secreted ligands. Merely as suggestive examples, we outline experiments that could potentially support or refute this extended hypothesis. A technique for patterning of the ECM components could be used to create a surface gradient in the concentration of heparin; this patterned substrate could then be used for migration studies of autocrine cells expressing heparin-binding EGF. Our extended hypothesis would predict that the static gradient of heparin would lead to chemotaxis of autocrine cells toward the higher concentration of heparin; the effect should be abolished by the addition of antibodies blocking the surface receptors. If successful, this experiment would demonstrate that the composition of the ECM can affect cell physiology (in this case, cell migration) by perturbing the operation of autocrine loops. Presumably, similar studies could be performed using other ECM components such as collagen or fibronectin. Another experiment, aimed at demonstrating this effect at the level of cell signaling, would follow the MAPK dynamics induced by exogenously added growth factors in cells plated on substrates with different levels of heparin.
A critical question arising in the design of anticancer therapies targeting autocrine loops is how to optimally select particular components within a signaling network to be targeted for pharmacological inhibition. Another question is how to choose among multiple antireceptor and antiligand antibodies, tyrosine kinase inhibitors, inhibitors of membrane-associated proteases that release autocrine ligands, and inhibitors of the downstream signaling components. Rational design of therapies that target systems as complex as autocrine loops may benefit from the further development and validation of our model. In particular, a combination of further modeling and parameter estimation techniques is required to convert our model to a practical tool for the analysis and eventually the design of radiation responses of autocrine cells. Within the last 2 yr, several groups have reported time-resolved measurements of reactive oxygen species (ROS) (46) generation and intracellular signaling activation in response to ionizing radiation (for review see Refs. 42 and 59). These experiments have identified several mechanisms by which radiation can impact the autocrine loop. By generating ROS, ionizing radiation can potentially inhibit receptor tyrosine phosphatases and cause ligand-independent receptor activation; at the same time, ROS can activate ligand-releasing proteases (74) and the components of the intracellular signaling pathways, such as Raf-1 (see Ref. 59 and references therein). A mechanistic description of these effects will be a natural extension of the model presented here. In the present version of the model, the signaling activity of the ligand-receptor complex ceases with its internalization, and the rate of ligand recycling is set to zero. The model can be made more quantitative by accounting for the effects of receptor and ligand recycling and signaling from early endosomes (3, 9, 22, 32, 65, 67, 71, 73) and for the effects of signaling through other pathways stimulated by the EGFR (33, 57, 69) . Given the fact that autocrine signaling through the EGFR loops has been identified as one of the major cytoprotective mechanisms determining the success of cancer radiotherapy (1, 35, 58) , we believe that this modeling effort is necessary.
APPENDIX A
Model Equations
Binding and transport. We consider the axially symmetrical spatial distribution of ligand around the cell. The governing equations and boundary conditions are
In the present version of the model, the diffusivity of the ligand (D) does not depend on its association with an antiligand antibody. The system of equations is rendered dimensionless by the following transformations
The cell radius scales the coordinate; the time (t) is scaled by the inverse dissociation rate constant; extracellular ligand concentrations are scaled by the equilibrium binding constant; the surface densities of free and occupied receptors are scaled by the density of receptors in the absence of ligand (R T ϵ s/kc). The rescaled problem takes the following form (see RESULTS for definitions of dimensionless groups Au, Da, ␦, and ␥)
The time scale of extracellular diffusion is defined by ⑀ ϭ r cell 2 koff/D. Dimensionless binding constants, k ϩ and k Ϫ , reflect the strength with which the secreted ligand is bound by the extracellular component: kϩ ϭ k on B Br cell 2 /D and kϪ ϭ k off B r cell 2 /D. For high values of the secreted growth factor diffusivity (⑀ Ͻ Ͻ 1), concentrations of soluble species evolve on the time scale that is much shorter than that of surface receptors and ligand-receptor complexes. In this regimen, the binding/transport model can be simplified by using a steadystate approximation for the concentration of endogenous ligand; we can solve for the value of this concentration at the surface of our autocrine cell
where W depends on the composition of the extracellular medium and the rate constants of the forward and reverse binding processes:
]. The pseudo-steady-state approximation (Eq. A14) for the concentration of secreted ligand leads to the following model for the dynamics of free and bound cell surface receptors
More subtle details of receptor binding and trafficking, such as dimerization, stoichiometric saturation of internalization, and endosomal sorting to recycling, could be easily incorporated into the model. Protease dynamics. The model is formulated in terms of P and Pa
After rescaling according to P ϭ k c P P/S p , P a ϭ k c P P a /S p , ϭ k c P /k e P , ϭ k a P /k e P , ϭ tk e P (A19) the system is converted to its dimensionless form
Signaling cascade. Let e 1P, e2P, and e3P denote the dimensionless (scaled by the total amount of the enzyme) concentrations of the active ("phosphorylated") form of the enzymes. The model for dynamics of e 1P, e2P, and e3P has the following form In this form, the equilibrium Michaelis constants (Km,i) are rescaled by the total amount of enzyme at a given stage of the cascade; V max is maximal reaction velocity. Coupled system. The input to the signaling cascade is given by I ϭ I 0 ϩ G2RTC , where I0 denotes (possibly time-dependent) input to the signaling network, independent of endog-enous ligand, and G2 quantifies the efficiency with which occupied receptor stimulates the input to the signaling cascade. The (scaled) rate of protease activation is given by ϭ 0 ϩ G3e3P, where is the rate of activation mediated by "MAPK-independent" processes. Finally, the rate of ligand secretion is Q ϳ Au ϭ G 1Pa. The integrated model of an autocrine cell then becomes (the units of time are now the same in all 3 modules of our autocrine loop) 
Materials and Experimental Methods
Reagents. Anti-p42 MAPK (sc-154AC) was obtained from Santa Cruz Biotechnology (Santa Cruz Biotechnologies, CA), the neutralizing monoclonal antibody to TGF-␣ (Ab-3) and control antibody to TFIID (Ab-2) from Calbiochem (San Diego, CA), and [␥-32 P]ATP from NEN. The enzyme-linked immunosorbent assay to measure TGF-␣ release was purchased from Oncogene Research Products (San Diego, CA), and studies were performed according to the manufacturer's instructions. Other materials were as described previously (16, 30) .
Culture of A431 cells. A431-TR25-EGFR antisense cells were plated at a density of 3.2 ϫ 10 4 cells/cm 2 and cultured for 4 days in RPMI 1640 medium supplemented with 5% (vol/vol) fetal calf serum at 37°C in 95% (vol/vol) air-5% (vol/vol) CO 2, as described previously (16) . Cells were cultured in reduced-serum (0.5% vol/vol) medium for 2 h before irradiation. Cells were at ϳ70% confluency at the time of irradiation.
Treatment of cells with ionizing radiation and cell homogenization. Cells were cultured as described above and serum starved for 12 h before irradiation (16) . In the experiments, anti-TGF-␣ antibody (1 g/ml medium) was added 60 min before irradiation. For media transfer assays, anti-TGF-␣ antibody (2 g) was added to recovered medium 120 min after irradiation, and the medium was incubated with antibody for 60 min before further use. A control antibody to the transcriptional regulator TFIID corresponding to the same monoclonal antibody subtype (IgG2) as the anti-TGF-␣ antibody was used as a control. Cells were irradiated using a 60 Co source at 1.8 Gy/min, to a total of 2 Gy. Time 0 is the time at which exposure to radiation ceased. After radiation treatment, cells were incubated for specified times, and then the medium was aspirated and snap frozen at Ϫ70°C on dry ice. Cells were homogenized as described previously (16, 30) .
Immunoprecipitation and assay of MAPK activity. Immunoprecipitates were incubated with [␥-32 P]ATP and myelin basic protein, as described elsewhere (16, 30) . 32 P incorporation into myelin basic protein was quantified by liquid scintillation spectroscopy, as described previously (16, 30) .
Data analysis. The effects of various treatments were compared using one-way analysis of variance and a twotailed t-test. Differences with P Ͻ 0.05 were considered statistically significant. Values are means Ϯ SE of multiple individual points from multiple separate experiments.
